Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03030287
Title A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors OncoMed Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado, Anschutz Medical Campus Aurora Colorado 80045 United States Details
H. Lee Moffitt Cancer Center & Research Institute, Inc. (Moffitt Cancer Center) Tampa Florida 33612 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
The University of Pennsylvania Health System Philadelphia Pennsylvania 19104 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
The University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field